Call Us: 1.800.873.5297

By

Roger Denton and Kristine Kraft of Schlichter, Bogard & Denton, LLP Report that the $100 Million NuvaRing Settlement Will Go Forward

Roger-Kris-200-86Roger Denton and Kristine Kraft of Schlichter, Bogard & Denton, LLP, Co-Lead Counsel in the NuvaRing Multidistrict Litigation, are pleased to announce that the $100 Million global settlement reached in February will go forward as planned. On February 7, 2014, United States District Court Judge Rodney W. Sippel approved a $100 Million settlement in the NuvaRing® Multidistrict Litigation In re: NuvaRing® Products Liability Litigation (MDL No. 1964, Case No. 08-md-1964). Under the terms of the settlement agreement, Merck had the right to abandon the deal (i.e., exercise “walk away rights”) if less than 95% of the eligible claimants refused to opt into the settlement program. The 95% participation threshold has been reached, so the settlement for the NuvaRing litigation will proceed.

Roger Denton states, “The settlement was reached after more than four years of litigation, after reviewing millions of pages of documents produced by Organon, and the completion of more than 100 depositions – both in the United States and in Europe.” He further states, “Approximately 3,800 claimants will share in this settlement. The settlement program is a simplified and cost effective method that will bring the most compensation to the injured claimants and is fully endorsed by Judge Rodney Sippel, the MDL judge in St. Louis, Judge Brian Martinotti, the presiding mass tort judge in New Jersey, as well as the court-appointed mediator, retired federal Judge Wayne Andersen of Chicago.” Denton adds, “We are pleased that there is a high participation in the settlement program. This settlement is an outstanding result for this hard fought litigation and is in the best interests of all women included in the settlement who have suffered an injury associated with the use of NuvaRing®.”

Roger Denton and Kristine Kraft, both leaders in the national NuvaRing® litigation, represent numerous women and families who allege to have suffered serious injuries or even lost loved ones after using NuvaRing®. From their intense work as leaders in the national litigation, Denton and Kraft have been speaking out about the dangers of NuvaRing® and the lack of adequate warnings regarding the risks posed to women. Their efforts have garnered national attention for this important topic, including a January 2014 Vanity Fair article entitled “Danger in the Ring” and a January 2014 Huffington Post article entitled “Side Effects May Include Death.” Now, Denton and Kraft will appear on CNN’s “Anderson Cooper 360” in a 3-part series to further discuss the litigation, the global settlement reached in the MDL, the dangers of such birth control products, and the need for adequate warnings within the product labeling to appropriately inform women of the inherent risks.

 

About Schlichter, Bogard & Denton, LLP

Schlichter, Bogard & Denton, LLP is a unique law firm that has held numerous leadership positions in other national litigations involving dangerous pharmaceutical medications and unsafe medical devices, including but not limited to: In re: Pradaxa (Dabigatran Etexilate) Products Liability (MDL 2385), In re: Yasmin® and Yaz® (Drospirenone) Marketing and Sales Practices and Products Liability Litigation (MDL 2100), In re: Gadolinium-Based Contrast Products Liability Litigation (MDL 1909), and In re: Ortho Evra® Products Liability Litigation (MDL 1742).

The Pharmaceuticals and Medical Litigation Department at Schlichter, Bogard & Denton aggressively represent clients who allege to have suffered injuries as a result of dangerous pharmaceutical medications and unsafe medical devices. The attorneys at Schlichter, Bogard & Denton, LLP who represent such victims include Roger Denton, Kristine Kraft, Beth Wilkins Flieger, Ashley Brittain Landers, and Tara Rocque. With hard work, creative thinking, and strong trial skills, we have earned an outstanding nationwide reputation by representing thousands of individuals who have suffered serious and life-threatening injuries, or even death.

If you or a loved has suffered injuries as a result of dangerous pharmaceutical medications or unsafe medical devices, please contact the attorneys at Schlichter, Bogard & Denton, LLP toll-free at 1-800-873-5297 for your confidential and free consultation.

Schlichter, Bogard & Denton, LLP also welcomes the opportunity to work with other attorneys on these types of cases. Schlichter, Bogard & Denton, LLP is available to either handle these cases or work as co-counsel, so other attorneys are invited to contact an attorney at the firm to explore this opportunity.

The choice of a lawyer is an important decision and should not be based solely on advertisements. The cases discussed do not predict outcomes in future cases. Past results afford no guarantee of future results and every case is different and must be judged on its own merits.

000-017   000-080   000-089   000-104   000-105   000-106   070-461   100-101   100-105  , 100-105  , 101   101-400   102-400   1V0-601   1Y0-201   1Z0-051   1Z0-060   1Z0-061   1Z0-144   1z0-434   1Z0-803   1Z0-804   1z0-808   200-101   200-120   200-125  , 200-125  , 200-310   200-355   210-060   210-065   210-260   220-801   220-802   220-901   220-902   2V0-620   2V0-621   2V0-621D   300-070   300-075   300-101   300-115   300-135   3002   300-206   300-208   300-209   300-320   350-001   350-018   350-029   350-030   350-050   350-060   350-080   352-001   400-051   400-101   400-201   500-260   640-692   640-911   640-916   642-732   642-999   700-501   70-177   70-178   70-243   70-246   70-270   70-346   70-347   70-410   70-411   70-412   70-413   70-417   70-461   70-462   70-463   70-480   70-483   70-486   70-487   70-488   70-532   70-533   70-534   70-980   74-678   810-403   9A0-385   9L0-012   9L0-066   ADM-201   AWS-SYSOPS   C_TFIN52_66   c2010-652   c2010-657   CAP   CAS-002   CCA-500   CISM   CISSP   CRISC   EX200   EX300   HP0-S42   ICBB   ICGB   ITILFND   JK0-022   JN0-102   JN0-360   LX0-103   LX0-104   M70-101   MB2-704   MB2-707   MB5-705   MB6-703   N10-006   NS0-157   NSE4   OG0-091   OG0-093   PEGACPBA71V1   PMP   PR000041   SSCP   SY0-401   VCP550  

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.